Correspondence
- PMID: 33840787
- DOI: 10.1097/IAE.0000000000003184
Correspondence
Comment in
-
Reply.Retina. 2021 Sep 1;41(9):e56-e58. doi: 10.1097/IAE.0000000000003183. Retina. 2021. PMID: 34432748 No abstract available.
Comment on
-
THE ANGIOPOIETIN/TIE PATHWAY IN RETINAL VASCULAR DISEASES: A Review.Retina. 2021 Jan 1;41(1):1-19. doi: 10.1097/IAE.0000000000003003. Retina. 2021. PMID: 33136975 Review.
References
-
- Heier JS, Singh RP, Wykoff CC, et al. The angiopoietin/tie pathway in retinal vascular diseases: a Review. Retina 2021;41:1–19.
-
- Hammes HP, Lin J, Wagner P, et al. Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy. Diabetes 2004;53:1104–1110.
-
- Hammes HP, Feng Y, Pfister F, Brownlee M. Diabetic retinopathy: targeting vasoregression. Diabetes 2011;60:9–16.
-
- Wolf A, Langmann T. Anti-VEGF-A/ANG2 combotherapy limits pathological angiogenesis in the eye: a replication study. EMBO Mol Med 2019;11:e10362.
-
- De La Huerta I, Kim SJ, Sternberg P. Faricimab combination therapy for sustained efficacy in neovascular age-related macular degeneration. JAMA Ophthalmol 2020;138:972–973.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
